P. Kumar Agency

The Mounjaro 2.5 mg tirzepatide injection is the standard starting dose used for treatment initiation in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It is a once-weekly subcutaneous injection that is not intended for long-term glycemic control itself, but rather to help the body adjust to the medication. 

The Mounjaro 5mg tirzepatide injection is the standard starting dose used for treatment initiation in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It is a once-weekly subcutaneous injection that is not intended for long-term glycemic control itself, but rather to help the body adjust to the medication. 

The 7.5 mg Mounjaro (tirzepatide) injection is a once-weekly prescription medication used in adults as an adjunct to diet and exercise to improve blood sugar control in type 2 diabetes and for chronic weight management in those who are obese or overweight with a weight-related condition

The Mounjaro 10 mg tirzepatide injection is a once-weekly prescription medication used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes. It is also effective for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition. 

The 15 mg dose of Mounjaro (tirzepatide) injection is the maximum approved dosage, used as a once-weekly subcutaneous injection for the treatment of type 2 diabetes and, under the brand name Zepbound, for chronic weight management in eligible adults. 

Mounjaro is used to help lower blood sugar levels in people with type 2 diabetes. Mounjaro may also be used for other conditions as determined by your healthcare provider.

The 12.5 mg dose of Mounjaro (tirzepatide) injection is a prescription medication primarily used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes and is also approved in some regions for chronic weight management in adults with obesity or who are overweight with a related health condition.